Factors Associated With Normal Flow (TIMI 3) After Thrombolysis With Streptokinase in ST-Elevation Myocardial

Karthik Raghuram1, Surendran Deepanjali1, Ajith Ananthakrishna Pillai2

  • 1Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND.

Cureus
|February 22, 2021
PubMed

Insights

ST-segment recovery after streptokinase (STK) thrombolysis predicts successful reperfusion in ST-elevation myocardial infarction (STEMI) patients. Hematological markers like neutrophil-lymphocyte ratio (NLR) and mean platelet volume (MPV) did not predict reperfusion in this study.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Emergency Medicine

Background:

  • Streptokinase (STK) thrombolysis is a primary reperfusion therapy for ST-elevation myocardial infarction (STEMI) in India.
  • Achieving Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 via coronary angiography (CAG) is crucial for better patient outcomes.
  • Previous research suggested hematological indices, including neutrophil-lymphocyte ratio (NLR) and mean platelet volume (MPV), might predict TIMI 3 flow.

Purpose of the Study:

  • To investigate clinical, electrocardiographic, and hematological parameters associated with TIMI 3 flow after STK thrombolysis in STEMI patients.
  • To evaluate the predictive value of NLR and MPV for achieving TIMI 3 flow post-thrombolysis.

Main Methods:

  • A prospective study of 201 adult STEMI patients presenting within 12 hours of chest pain onset.
  • Blood samples collected pre-thrombolysis for NLR and MPV estimation.
  • Coronary angiography (CAG) timing determined by cardiologists; one-month follow-up post-discharge.

Main Results:

  • TIMI 3 flow was achieved in 56% of patients.
  • ST-segment recovery of ≥50% at 90 minutes post-thrombolysis was significantly associated with TIMI 3 flow (adjusted OR 3.47).
  • NLR and MPV showed no significant association with TIMI 3 flow.

Conclusions:

  • ST-segment recovery ≥50% at 90 minutes is an independent predictor of TIMI 3 flow after STK thrombolysis in STEMI.
  • NLR and MPV are not reliable predictors of reperfusion success in this context.
  • Early electrocardiographic changes are more indicative of successful reperfusion than pre-treatment hematological markers.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
284
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
89
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
530
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
109
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95